Through the above analysis, we identified that PSMB9 can be used as the prognostic marker; immune analysis was also implemented to confirm the relationship with tumor immune environment and its prospect in tumor immunotherapy application in patients with LGG. Here, PSMB9 is linked to neoplasm.